Treatment Action Group | 2026 Pipeline Reports: Antiretroviral therapy, PrEP, Long-acting therapies

Treatment Action Group (TAG) released three 2026 Pipeline Reports, with more to follow later this year:

Each report is a comprehensive assessment on clinical trials and treatment development and consolidates cutting-edge information and analysis into one report.

The annually published Pipeline Reports are designed to increase accessibility to science for public health activists, scholars, and researchers.

Source : Treatment Action Group